Home › Companies › Novavax, Inc. › 2025-2026

Novavax, Inc. 2025-2026 Proxy Voting Records

Compiled from SEC Form N-PX filings and Novavax, Inc.’s Form 8-K, filed June 23, 2026 (Item 5.07 on EDGAR). Page generated October 14, 2026.

  • 7Reported items
  • 269Asset managers
  • 1,478Fund votes
  • June 18, 2026Meeting date

Results at a glance

Meeting of June 18, 2026: 7 items on Novavax, Inc.’s Form 8-K, filed June 23, 2026: 3 elected · 4 approved.

Material dissent

Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided

Proxy season: 2023-2024 2024-2025 2025-2026

Explore Novavax, Inc. in the interactive database Compare manager voting policies

Official 2025-2026 meeting results reported by Novavax, Inc.

These tallies are Novavax, Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 23, 2026 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

Novavax, Inc. — official shareholder meeting results, meeting held June 18, 2026
Ballot itemForAgainst AbstainWithheldBroker non-votesSupport (of votes cast)Reported outcomeVoting standard
Elect Director: John C. Jacobs 43,479,77727,127,783768,456 --27,742,750 62%Elected—
Elect Director: Gregg H. Alton, J.D. 41,352,50429,160,512863,000 --27,742,750 59%Elected—
Elect Director: Richard J. Rodgers 42,600,08827,885,191890,737 --27,742,750 60%Elected—
2. The compensation of the Company's named executive officers 35,779,46134,858,658737,897 --27,742,750 50.7%Approved—
3. The amendment and restatement of the Novavax, Inc 38,225,76832,606,575543,673 --27,742,750 54.0%Approved—
4. The amendment and restatement of the Novavax, Inc 35,988,15433,864,9731,522,889 --27,742,750 51.5%Approved—
5. The appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026 72,876,82723,562,0922,679,847 ---- 76%Approved—

This meeting is also recorded here as June 17, 2026; both records come from the same filing, so the date should be checked against it.

Source: Novavax, Inc., Form 8-K, filed with the SEC on June 23, 2026 — read the filing on EDGAR.

How asset managers voted at the Novavax, Inc. 2025-2026 meeting

Each item below shows how the 269 asset managers that disclosed a Novavax, Inc. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of Novavax, Inc.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. Elect Director: Gregg H. Alton, J.D.

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 4 wordings of this item as funds reported it.

59% Majority: yes · of votes cast

FOR 59%AGAINST
FOR: 41,352,504AGAINST: 29,160,512
Details: description as filed, official tally, votes by 53 asset managers

Description as filed by funds: Election of three Class I directors to serve on the Board of Directors, each for a three-year term expiring at the 2029 Annual Meeting of Stockholders: Gregg H. Alton, J.D.

Novavax, Inc.’s own tally for this item (“Elect Director: Gregg H. Alton, J.D.”): 41,352,504 for, 29,160,512 against, per its Form 8-K filed June 23, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The final voting results for the proposals considered and voted upon at the Annual Meeting, each of which were described in the Company's Definitive Proxy Statement on Schedule 14A filed with the Securities and Exchange Commission on April 27, 2026, are as follows: Proposal 1 : Stockholders elected…”
Support: 59% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 53 asset managers below reported 10,822,603 for, 702,325 against, 11,633 abstained.

FOR
FOR: 10,822,603AGAINST: 702,325ABSTAIN: 11,633
Largest asset managers voting on “Election of three Class I directors to serve on the Board of Directors, each for a three-year term expiring at” at Novavax, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard3,111,4892,919 30For
State Street2,121,2520 00For
Fidelity1,317,314312,281 00Mixed
Charles Schwab1,396,4660 00For
BlackRock1,332,1010 00For
First Trust340,4480 00For
WisdomTree266,1420 00For
ALPS ETF Trust160,6820 00For
Equitable32,634108,250 00Mixed
MFS0136,573 00Against
ProShares119,5150 00For
Lincoln Financial100,9000 00For
Direxion Shares ETF Trust94,3050 00For
SEI Exchange Traded Funds070,226 00Against
Jackson National59,4860 00For
TIAA48,6160 00For
AIG/SunAmerica41,0670 00For
Bridge Builder Trust36,2970 00For
ETF Opportunities Trust34,3430 00For
Voya24,1720 00For
John Hancock23,6750 00For
SEI023,268 00Against
AQR22,3210 00For
DWS20,9310 00For
Goldman Sachs19,9810 00For

Showing the 25 largest of 53 asset managers. See all 53 in the interactive database.

2. Elect Director: John C. Jacobs

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 4 wordings of this item as funds reported it.

62% Majority: yes · of votes cast

FOR 62%AGAINST
FOR: 43,479,777AGAINST: 27,127,783
Details: description as filed, official tally, votes by 53 asset managers

Description as filed by funds: Election of three Class I directors to serve on the Board of Directors, each for a three-year term expiring at the 2029 Annual Meeting of Stockholders: John C. Jacobs

Novavax, Inc.’s own tally for this item (“Elect Director: John C. Jacobs”): 43,479,777 for, 27,127,783 against, per its Form 8-K filed June 23, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The final voting results for the proposals considered and voted upon at the Annual Meeting, each of which were described in the Company's Definitive Proxy Statement on Schedule 14A filed with the Securities and Exchange Commission on April 27, 2026, are as follows: Proposal 1 : Stockholders elected…”
Support: 62% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 53 asset managers below reported 11,212,567 for, 312,362 against, 11,632 abstained.

FOR
FOR: 11,212,567AGAINST: 312,362ABSTAIN: 11,632
Largest asset managers voting on “Election of three Class I directors to serve on the Board of Directors, each for a three-year term expiring at” at Novavax, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard3,114,32881 20For
State Street2,121,2520 00For
Fidelity1,317,314312,281 00Mixed
Charles Schwab1,396,4660 00For
BlackRock1,332,1010 00For
First Trust340,4480 00For
WisdomTree266,1420 00For
ALPS ETF Trust160,6820 00For
Equitable140,8840 00For
MFS136,5730 00For
ProShares119,5150 00For
Lincoln Financial100,9000 00For
Direxion Shares ETF Trust94,3050 00For
SEI Exchange Traded Funds70,2260 00For
Jackson National59,4860 00For
TIAA48,6160 00For
AIG/SunAmerica41,0670 00For
Bridge Builder Trust36,2970 00For
ETF Opportunities Trust34,3430 00For
Voya24,1720 00For
John Hancock23,6750 00For
SEI23,2680 00For
AQR22,3210 00For
DWS20,9310 00For
Goldman Sachs19,9810 00For

Showing the 25 largest of 53 asset managers. See all 53 in the interactive database.

3. Elect Director: Richard J. Rodgers

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 4 wordings of this item as funds reported it.

60% Majority: yes · of votes cast

FOR 60%AGAINST
FOR: 42,600,088AGAINST: 27,885,191
Details: description as filed, official tally, votes by 53 asset managers

Description as filed by funds: Election of three Class I directors to serve on the Board of Directors, each for a three-year term expiring at the 2029 Annual Meeting of Stockholders: Richard J. Rodgers

Novavax, Inc.’s own tally for this item (“Elect Director: Richard J. Rodgers”): 42,600,088 for, 27,885,191 against, per its Form 8-K filed June 23, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The final voting results for the proposals considered and voted upon at the Annual Meeting, each of which were described in the Company's Definitive Proxy Statement on Schedule 14A filed with the Securities and Exchange Commission on April 27, 2026, are as follows: Proposal 1 : Stockholders elected…”
Support: 60% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 53 asset managers below reported 11,095,078 for, 429,850 against, 11,633 abstained.

FOR
FOR: 11,095,078AGAINST: 429,850ABSTAIN: 11,633
Largest asset managers voting on “Election of three Class I directors to serve on the Board of Directors, each for a three-year term expiring at” at Novavax, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard3,108,6365,771 30For
State Street2,118,5782,674 00For
Fidelity1,317,314312,281 00Mixed
Charles Schwab1,396,4660 00For
BlackRock1,332,1010 00For
First Trust340,4480 00For
WisdomTree266,1420 00For
ALPS ETF Trust160,6820 00For
Equitable32,634108,250 00Mixed
MFS136,5730 00For
ProShares119,5150 00For
Lincoln Financial100,9000 00For
Direxion Shares ETF Trust94,3050 00For
SEI Exchange Traded Funds70,2260 00For
Jackson National59,4860 00For
TIAA48,6160 00For
AIG/SunAmerica41,0670 00For
Bridge Builder Trust36,2970 00For
ETF Opportunities Trust34,3430 00For
Voya24,1720 00For
John Hancock23,6750 00For
SEI23,2680 00For
AQR22,3210 00For
DWS20,9310 00For
Goldman Sachs19,9810 00For

Showing the 25 largest of 53 asset managers. See all 53 in the interactive database.

4. AMENDMENT AND RESTATEMENT OF THE NOVAVAX, INC. AMENDED AND RESTATED 2015 STOCK INCENTIVE PLAN, AS AMENDED, TO INCREASE…

No official matchCOMPENSATION

Combines 2 wordings of this item as funds reported it.

99.9% of fund votes cast · no official result

FOR
Details: description as filed, votes by 54 asset managers

Description as filed by funds: AMENDMENT AND RESTATEMENT OF THE NOVAVAX, INC. AMENDED AND RESTATED 2015 STOCK INCENTIVE PLAN, AS AMENDED, TO INCREASE THE NUMBER OF SHARES OF COMMON STOCK AVAILABLE FOR ISSUANCE THEREUNDER BY 9,400,000 SHARES.

The 54 asset managers below reported 11,497,976 for, 9,397 against, 11,632 abstained. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 11,497,976AGAINST: 9,397ABSTAIN: 11,632
Largest asset managers voting on “AMENDMENT AND RESTATEMENT OF THE NOVAVAX, INC. AMENDED AND RESTATED 2015 STOCK INCENTIVE PLAN, AS AMENDED, TO ” at Novavax, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard3,108,6225,786 20For
State Street2,118,5152,737 00For
Fidelity1,629,5950 00For
Charles Schwab1,396,4660 00For
BlackRock1,332,1010 00For
First Trust340,4480 00For
WisdomTree266,1420 00For
ALPS ETF Trust160,6820 00For
Equitable140,8840 00For
MFS136,5730 00For
ProShares119,5150 00For
Lincoln Financial100,9000 00For
Direxion Shares ETF Trust94,3050 00For
SEI Exchange Traded Funds70,2260 00For
Jackson National59,4860 00For
TIAA48,6160 00For
AIG/SunAmerica41,0670 00For
Bridge Builder Trust36,2970 00For
ETF Opportunities Trust34,3430 00For
Voya24,1720 00For
John Hancock23,6750 00For
SEI23,2680 00For
AQR22,3210 00For
DWS20,9310 00For
Goldman Sachs19,9810 00For

Showing the 25 largest of 54 asset managers. See all 54 in the interactive database.

5. Amendment and restatement of the Novavax, Inc. 2013 Employee Stock Purchase Plan, as amended (the "ESPP"), to increase…

No official matchCOMPENSATION

Combines 3 wordings of this item as funds reported it.

86% of fund votes cast · no official result

FOR
Details: description as filed, votes by 52 asset managers

Description as filed by funds: Amendment and restatement of the Novavax, Inc. 2013 Employee Stock Purchase Plan, as amended (the "ESPP"), to increase the number of shares of Common Stock available for issuance under the ESPP by 1,000,000 shares, such that the number of shares available for issuance is the lesser of (a) 3,375,888 shares of Common Stock increased on January 1 of each year by 5% of the share pool and (b) 4,820,564 shares of Common Stock.

The 52 asset managers below reported 9,945,388 for, 1,572,639 against, 5 abstained. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 9,945,388AGAINST: 1,572,639ABSTAIN: 5
Largest asset managers voting on “Amendment and restatement of the Novavax, Inc. 2013 Employee Stock Purchase Plan, as amended (the "ESPP"), to ” at Novavax, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard3,105,7818,625 50For
State Street2,117,9473,305 00For
Fidelity1,629,5950 00For
Charles Schwab01,396,466 00Against
BlackRock1,332,1010 00For
First Trust340,4480 00For
WisdomTree266,1420 00For
ALPS ETF Trust160,6820 00For
Equitable140,8840 00For
MFS136,5730 00For
ProShares119,5150 00For
Lincoln Financial100,9000 00For
Direxion Shares ETF Trust94,3050 00For
SEI Exchange Traded Funds070,226 00Against
Jackson National59,4860 00For
TIAA48,6160 00For
AIG/SunAmerica41,0670 00For
Bridge Builder Trust36,2970 00For
ETF Opportunities Trust34,3430 00For
Voya24,1720 00For
John Hancock23,6750 00For
SEI023,268 00Against
AQR22,3210 00For
DWS20,9310 00For
Goldman Sachs019,981 00Against

Showing the 25 largest of 52 asset managers. See all 52 in the interactive database.

6. 2. The compensation of the Company's named executive officers

Official resultFund totals may overlapSECTION 14A SAY-ON-PAY VOTESReported outcome: Approved

Combines 10 wordings of this item as funds reported it.

50.7% Approved · of votes cast

FOR 50.7%AGAINST
FOR: 35,779,461AGAINST: 34,858,658
Details: description as filed, official tally, votes by 269 asset managers

Description as filed by funds: The approval, on an advisory basis, of the compensation of our Named Executive Officers.

Novavax, Inc.’s own tally for this item (“2. The compensation of the Company's named executive officers”): 35,779,461 for, 34,858,658 against — passed, per its Form 8-K filed June 23, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal 2 : Stockholders approved, on an advisory basis, the compensation of the Company's named executive officers:”
Support: 50.7% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 53 asset managers voting on “The approval, on an advisory basis, of the compensation of our Named Executive Officers.” at Novavax, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard3,036,56777,842 20For
State Street2,118,8022,450 00For
Fidelity1,313,214316,381 00Mixed
Charles Schwab1,396,4660 00For
BlackRock1,332,1010 00For
First Trust0340,448 00Against
WisdomTree266,1420 00For
ALPS ETF Trust0160,682 00Against
Equitable32,634108,250 00Mixed
MFS136,5730 00For
ProShares0119,515 00Against
Lincoln Financial100,9000 00For
Direxion Shares ETF Trust094,305 00Against
SEI Exchange Traded Funds70,2260 00For
Jackson National59,4860 00For
TIAA48,6160 00For
AIG/SunAmerica041,067 00Against
Bridge Builder Trust36,2970 00For
ETF Opportunities Trust34,3430 00For
Voya24,1720 00For
John Hancock023,675 00Against
SEI23,2680 00For
AQR022,321 00Against
DWS020,931 00Against
Goldman Sachs19,9810 00For

Fund voting reports, all 53 managers: 10,124,936 for, 1,399,992 against, 11,632 abstained. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 232 asset managers voting on “The approval, on an advisory basis, of the compensation of our Named Executive Officers.” at Novavax, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
SHAH CAPITAL MANAGEMENT014,830,349 00Against
BlackRock2,503,66245,871 6650For
DE Shaw02,174,921 00Against
State Street1,889,69327,167 00For
GEODE CAPITAL MANAGEMENT, LLC1,421,1770 00For
Charles Schwab1,396,5850 00For
MARSHALL WACE, LLP1,192,1930 00For
Northern Trust0745,015 00Against
PACIFIC INVESTMENT MANAGEMENT CO LLC0571,145 00Against
Assenagon Asset Management S.A.0368,235 00Against
Goldman Sachs324,75311,898 00For
Fidelity0334,607 00Against
MELLON INVESTMENTS Corp273,8530 00For
Vanguard204,9085,975 00For
UBS0209,026 00Against
MASSACHUSETTS FINANCIAL SERVICES CO /MA/191,9990 00For
T. Rowe Price0179,940 00Against
Two Sigma0167,747 00Against
AllianceBernstein0162,413 00Against
PARAMETRIC PORTFOLIO ASSOCIATES LLC138,4960 00For
SEI128,9920 00For
AQR0108,403 00Against
Rafferty Asset Management, LLC094,305 00Against
OPPENHEIMER & CO INC80,2590 00For
Invesco078,015 00Against

Institutional-manager reports, all 232 managers: 10,172,953 for, 20,647,815 against, 1,337 abstained. Showing the 25 largest; see all in the interactive database.

7. 5. The appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal…

Official resultAUDIT-RELATEDReported outcome: Approved

Combines 2 wordings of this item as funds reported it.

76% Approved · of votes cast

FOR 76%AGAINST
FOR: 72,876,827AGAINST: 23,562,092
Details: description as filed, official tally, votes by 53 asset managers

Description as filed by funds: RATIFICATION OF THE APPOINTMENT OF ERNST & YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2026.

Novavax, Inc.’s own tally for this item (“5. The appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026”): 72,876,827 for, 23,562,092 against — passed, per its Form 8-K filed June 23, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal 5 : Stockholders ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026:”
Support: 76% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 53 asset managers below reported 11,524,803 for, 123 against, 11,635 abstained.

FOR
FOR: 11,524,803AGAINST: 123ABSTAIN: 11,635
Largest asset managers voting on “RATIFICATION OF THE APPOINTMENT OF ERNST & YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR ” at Novavax, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard3,114,34760 50For
State Street2,121,18963 00For
Fidelity1,629,5950 00For
Charles Schwab1,396,4660 00For
BlackRock1,332,1010 00For
First Trust340,4480 00For
WisdomTree266,1420 00For
ALPS ETF Trust160,6820 00For
Equitable140,8840 00For
MFS136,5730 00For
ProShares119,5150 00For
Lincoln Financial100,9000 00For
Direxion Shares ETF Trust94,3050 00For
SEI Exchange Traded Funds70,2260 00For
Jackson National59,4860 00For
TIAA48,6160 00For
AIG/SunAmerica41,0670 00For
Bridge Builder Trust36,2970 00For
ETF Opportunities Trust34,3430 00For
Voya24,1720 00For
John Hancock23,6750 00For
SEI23,2680 00For
AQR22,3210 00For
DWS20,9310 00For
Goldman Sachs19,9810 00For

Showing the 25 largest of 53 asset managers. See all 53 in the interactive database.

Largest Novavax, Inc. shareholders voting in 2025-2026

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 164,438,119 shares outstanding at the time of that meeting.

Fund voting reports: top Novavax, Inc. shareholders by shares voted on “The approval, on an advisory basis, of the compensation of our Named Executive Officers.”, 2025-2026
#Asset manager % of shares outstanding
1Vanguard 1.89%
2State Street 1.29%
3Fidelity 0.99%
4Charles Schwab 0.85%
5BlackRock 0.81%
6First Trust 0.21%
7WisdomTree 0.16%
8ALPS ETF Trust 0.10%
9Equitable 0.09%
10MFS 0.08%
Institutional-manager reports: top Novavax, Inc. shareholders by shares voted on “The approval, on an advisory basis, of the compensation of our Named Executive Officers.”, 2025-2026
#Asset manager % of shares outstanding
1SHAH CAPITAL MANAGEMENT 9.02%
2BlackRock 1.55%
3DE Shaw 1.32%
4State Street 1.17%
5GEODE CAPITAL MANAGEMENT, LLC 0.86%
6Charles Schwab 0.85%
7MARSHALL WACE, LLP 0.73%
8Northern Trust 0.45%
9PACIFIC INVESTMENT MANAGEMENT CO LLC 0.35%
10Assenagon Asset Management S.A. 0.22%

Reported Novavax, Inc. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.

Novavax, Inc. holdings and ownership disclosed for the 2025-2026 proxy season
Holder % outstanding Disclosure
Vanguard Group 9.41% 13F
Shah Capital Management 8.95% 13D
BlackRock 7.81% 13F
STATE STREET CORPORATION 7.14% 13G
D.E. Shaw 4.92% 13F
BANK OF AMERICA CORP /DE/ 4.05% 13G
Morgan Stanley 2.26% 13F
Citadel Advisors 1.17% 13F
Goldman Sachs 1.09% 13F
Point72 0.94% 13F

Percentages above are of 164,438,119 shares outstanding, as reported by Novavax, Inc. on its Form 10-Q dated April 30, 2026 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Novavax, Inc.’s 10-Q dated April 30, 2026. This page is a static snapshot rebuilt weekly on October 14, 2026; a live search always shows the current data.

At Novavax, Inc.'s shareholder meeting held June 18, 2026, in the 2025-2026 proxy season, 269 asset managers reported how they voted in their SEC Form N-PX filings, covering 1,478 separate fund positions. Their filings are grouped here into 7 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — The approval, on an advisory basis, of the compensation of our Named Executive Officers. — Novavax, Inc.'s filing reports the proposal as approved, with 50.7% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: Novavax, Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 23, 2026.

Novavax, Inc. proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).

Download data (CSV): ballot items · votes by manager · column guide.